Rapid epitope identification from complex class-II-restricted T-cell antigens.
نویسندگان
چکیده
The identification of CD4 + + T-cell epitopes is a laborious and tedious process. Various computer-assisted algorithms have been designed to assist in this process by predicting potential MHC-binding epitopes. Recently, the novel approach of using soluble MHC class II tetramers as a tool to identify T-cell epitopes has been developed successfully. We show that the T-cell epitopes identified using MHC tetramers are also predicted by a computer-assisted algorithm to bind to the same MHC molecule. We propose that epitope mapping using the MHC-tetramer-guided approach, in conjunction with predictive computer algorithms, will allow the rapid identification of T-cell epitopes from large proteins. The trimolecular interaction between MHC, peptide and T-cell receptor (TCR) provides the structural basis for the antigen (Ag) specificity of T-cell recognition. There are two key energetic determinants of this specificity: the binding interaction between MHC and peptide; and the binding of the TCR to the combined MHC–peptide complex. The former interaction has been studied well using peptide-binding assays to delineate the structural determinants of a peptide that allow energetically favorable binding to particular MHC molecules. Data from these studies have led to the development of computer-assisted algorithms, by which the sequences of large proteins can be scanned to predict individual peptides that might bind to distinct MHC molecules 1–5. The interaction of the TCR with MHC–peptide complexes has also been studied extensively, and has led to the recent development of MHC-tetramer technologies, in which soluble MHC–peptide complexes are used to bind to Ag-specific T cells present in heterogeneous lymphocyte populations 6–10. In the past, studies relied on a working knowledge of a particular peptide that binds to a specific MHC. Recently, soluble-MHC technology has been used to identify novel Ag-specific T cells and their restricted peptides in the absence of any knowledge of MHC-binding epitopes from the protein. MHC–mixed-peptide complexes were generated from a range of short, overlapping peptide sequences encompassing the whole protein, such that each MHC–mixed-peptide complex contains only a subset of all peptides. These complexes were used to identify and clone Ag-specific reactive T cells 11. Success in using this approach relies on the assumption that only a small fraction of the peptide sequences from any given protein is capable of binding to a particular MHC. This method of identifying Ag-specific T cells and their previously unknown epitopes has been named tetramer-guided epitope mapping (TGEM). In the light of these developments, we have examined …
منابع مشابه
Identification of Mycobacterium tuberculosis CTL Epitopes Restricted by HLA-A*0201 in HHD Mice
CD8+ T cells are thought to play an important role in protective immunity to tuberculosis. The major histocompatibility complex class I subtype HLA-A*0201 is one of the most prevalent class I alleles, with a frequency of over 30% in most populations. HLA-A*0201 transgenic, H-2Db/mouse beta2-microglobulin double-knockout mice (HHD) which express human HLA-A*0201 but no mouse class I, was shown t...
متن کاملIdentification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells.
CD4+ T cells play critical roles in initiating, regulating, and maintaining antitumor immune responses. One way to improve current tumor vaccines that mainly induce CTLs would be to activate antigen-specific CD4+ T cells that recognize MHC class II restricted tumor associated antigens. Human telomerase reverse transcriptase (hTRT) is preferentially expressed by various tumors and, therefore, co...
متن کاملRevelation of a cryptic major histocompatibility complex class II-restricted tumor epitope in a novel RNA-processing enzyme.
CD4+ T-cell responses against human tumor antigens are a potentially critical component of the antitumor immune response. Molecular methods have been devised for rapidly identifying MHC class II-restricted tumor antigens and elucidating the recognized epitopes. We describe here the identification of neo-poly(A) polymerase (neo-PAP), a novel RNA processing enzyme overexpressed in a variety of hu...
متن کاملIdentification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen.
The melanocyte-associated antigen gp100 constitutes one of the most attractive targets for T-cell-based immunotherapy against malignant melanoma. Although several MHC class I-restricted epitopes have been identified for CTLs, thus far, only one MHC class II T helper epitope (restricted by HLA-DR4) has been described in the literature. Using an algorithm to identify promiscuous helper T-cell epi...
متن کاملIsolation of human CD4/CD8 double-positive, graft-versus-host disease-protective, minor histocompatibility antigen-specific regulatory T cells and of a novel HLA-DR7-restricted HY-specific CD4 clone.
Minor histocompatibility (H) Ags are classically described as self-peptides derived from intracellular proteins that are expressed at the cell surface by MHC class I and class II molecules and that induce T cell alloresponses. We have isolated three different T cell populations from a skin biopsy of a patient suffering from acute graft-versus-host disease following sex-mismatched HLA-identical ...
متن کاملIdentification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells.
The EBV-encoded nuclear antigen 1 (EBNA1) is required for the maintenance and replication of the viral episome in EBV-transformed human B-lymphoblastoid cell lines. It is expressed in all EBV-associated tumors, making it a potentially important target for immunotherapy. However, this promise has not been realized, because an endogenously processed MHC class I-restricted T-cell epitope remains t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Trends in immunology
دوره 22 11 شماره
صفحات -
تاریخ انتشار 2001